| Literature DB >> 26774910 |
Wendy Chao1, Carlos Belmonte2, José M Benitez Del Castillo3, Anthony J Bron4, Harminder S Dua5, Kelly K Nichols6, Gary D Novack7, Stefan Schrader8, Mark D Willcox9, James S Wolffsohn10, David A Sullivan11.
Abstract
On March 21, 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the i(2) = initiating innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and supported by Dompé. The TFOS i(2) meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS i(2) meeting.Entities:
Keywords: Clinical trials; Dry Eye WorkShop II (DEWS II); Tear Film & Ocular Surface Society; drug development; dry eye disease (DED); i(2) = initiating innovation series
Mesh：
Year: 2016 PMID： 26774910 DOI： 10.1016/j.jtos.2015.11.003
Source DB: PubMed Journal: Ocul Surf ISSN： 1542-0124 Impact factor: 5.033